Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.
about
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patientsIs incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling.Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.Preservation of residual kidney function in hemodialysis patients: reviving an old concept.Dose of hemodialysis and survival: a marginal structural model analysisTiming of commencement of maintenance dialysis and mortality in young and older adults in SingaporeAssociation of baseline, longitudinal serum high-sensitive C-reactive protein and its change with mortality in peritoneal dialysis patients.Incremental short daily home hemodialysis: a case series.Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.The impact of an "acute dialysis start" on the mortality attributed to the use of central venous catheters: a retrospective cohort study.Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patientsCohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT).Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making.Lower residual renal function is a risk factor for depression and impaired health-related quality of life in Korean peritoneal dialysis patients.Predictors of quality of life of hemodialysis patients in IndiaOutcome of early initiation of peritoneal dialysis in patients with end-stage renal failure.Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) studyPrediction of Mortality in Incident Hemodialysis Patients: A Validation and Comparison of CHADS2, CHA2DS2, and CCI ScoresSerum β-trace protein and risk of mortality in incident hemodialysis patientsImpact of residual urine volume decline on the survival of chronic hemodialysis patients in Kinshasa.Family income is associated with quality of life in patients with chronic kidney disease in the pre-dialysis phase: a cross sectional studySignificance of residual renal function for phosphate control in chronic hemodialysis patients.Intradialytic Blood Pressure Abnormalities: The Highs, The Lows and All That Lies Between.Plasma Iohexol Clearance for Assessing Residual Kidney Function in Dialysis Patients.Estimating residual kidney function in dialysis patients without urine collectionSurvival by Dialysis Modality-Who Cares?Comparison of Clinical Outcome Between Twice-Weekly and Thrice-Weekly Hemodialysis in Patients With Residual Kidney Function.A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival.Infrequent dialysis: a new paradigm for hemodialysis initiation.Predialysis health, dialysis timing, and outcomes among older United States adultsClinical predictors of decline in nutritional parameters over time in ESRD.Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.Monitoring of inflammation in patients on dialysis: forewarned is forearmed.Health-related quality of life in different stages of renal failure.Preserving residual renal function in dialysis: what we know.Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.How Can We Improve the Quality of Life of Dialysis Patients?Interplay of volume, blood pressure, organ ischemia, residual renal function, and diet: certainties and uncertainties with dialytic management.Incremental Hemodialysis: The University of California Irvine Experience.Lower prevalence of chronic itch in haemodialysis patients on loop diuretics: results from GEHIS (German Epidemiological Hemodialysis Itch Study).
P2860
Q24193825-F1818E9D-FB92-45FC-9B39-C176E439EFCBQ30235108-CBD86651-0430-44D6-B02E-7AA9B9833079Q30248239-DC1D6186-56FA-49C7-8777-FD4CA846966EQ30250300-C87D3DD8-167C-40EF-A53C-ED0031C07518Q33723192-700DA5D8-4873-4758-80AE-63F47CE73E44Q33743628-1EBA9A4A-65EB-4695-9250-40D18D6C9060Q33869113-95296A2E-EDB1-4C3A-9D0F-5612DCA302C2Q33876429-FABFC1BA-D81A-488C-9A04-A47B5EC77D4EQ33954138-C71BD787-7DA0-4798-ADB8-6289B62785DAQ34356681-92A73109-E029-4361-8CDE-7710C6BB8563Q34639575-96147BDE-A588-41DE-B659-833E966EC81DQ34768530-90A00B0C-765E-4F78-8888-FD0D48C2F79EQ35574112-894EC65C-4943-4F8A-9342-F85EB0397E86Q35639050-8CFE17A6-7A80-46C9-8CB1-A07459A3CF1BQ35685985-1F14D82C-54B5-4E31-A600-D71AB4B6DE6DQ35730854-44409694-95DC-426D-AF8F-F9AAFB8C3F6EQ35929287-7A465641-7216-4C72-A0DF-5444597F3DA2Q36009279-77497385-318A-4B0D-B479-0D5C6FF53215Q36199548-29DF7263-8304-4A2C-AF47-9D572711A5A2Q36200137-3C058446-8BAE-4D96-B074-21D556B7BF2DQ36393758-A1AFFCC3-2FE9-4EA8-AC36-6716677D4614Q36466276-470D2241-F00C-434A-A88E-5188DE702EB5Q36600079-B220B155-6D0E-4865-A2FA-3171AFC2B302Q36728996-414A3AA1-74A7-450E-8C38-2F470668C9EDQ36805490-D2CDEAC2-2276-4E91-8A76-3E82FF266B3EQ36965163-2A4F52E7-23CA-4F8E-9BE1-E77CF03FEE4BQ37206145-BB9CBE29-9F99-477A-9279-C761962D2DB7Q37211311-28A1E244-AA9F-4375-95D4-39EF36FA112FQ37352176-159ADFDE-D372-4A5E-9A3F-E8F4553AD303Q37524145-5254210C-E089-4451-BFED-3BA50011492BQ37553051-CC522360-F3CA-443B-90A5-DB63E9312F94Q37582625-76089F42-4260-4658-AF36-3B491F2E8198Q37848040-C106F362-762F-4207-BE3E-75F0D34CA931Q37994729-51232B5C-65D3-40D6-834D-62249CFAF468Q38251207-60164844-BC02-4B0D-AA64-8ABF4A890760Q38664089-91A01469-281B-40DD-B606-880D2A7B95AEQ38693389-CBD61160-0135-4697-A4D7-5788795E207AQ38743790-C782587D-0D70-455E-93E9-E712275B6D55Q38745009-6D6EC3B9-6BA1-49BA-B48C-640AF13A6229Q38751548-5C2D6C91-9892-4926-9F4F-A39780017454
P2860
Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association of residual urine ...... Renal Disease (CHOICE) Study.
@ast
Association of residual urine ...... Renal Disease (CHOICE) Study.
@en
Association of residual urine ...... Renal Disease (CHOICE) Study.
@nl
type
label
Association of residual urine ...... Renal Disease (CHOICE) Study.
@ast
Association of residual urine ...... Renal Disease (CHOICE) Study.
@en
Association of residual urine ...... Renal Disease (CHOICE) Study.
@nl
prefLabel
Association of residual urine ...... Renal Disease (CHOICE) Study.
@ast
Association of residual urine ...... Renal Disease (CHOICE) Study.
@en
Association of residual urine ...... Renal Disease (CHOICE) Study.
@nl
P2093
P2860
P50
P1476
Association of residual urine ...... Renal Disease (CHOICE) Study.
@en
P2093
John H Sadler
Laura C Plantinga
Nancy E Fink
Neil R Powe
Rulan S Parekh
P2860
P304
P356
10.1053/J.AJKD.2010.03.020
P577
2010-06-03T00:00:00Z